Zürcher Kantonal Bank

Grand Resort Bad Ragaz is situated in the Heidiland holiday region of Eastern Switzerland. Europe’s leading wellbeing and medical health resort dates back to 1242. The health resort is supplemented by the renowned Medical Health Centre, as well as the Swiss Olympic Medical Center. The resort has two golf courses, the Kursaal Business & Events Center, a broad range of cultural activities, and its casino.

Founded in 2013, Embotech develops decision-making software solutions for autonomous systems. Its flagship product, FORCES Pro, enables complex control system design across industries such as automotive, energy, and robotics. Applications include wind turbine control, drone motion planning, advanced driver assistance systems (ADAS), spacecraft landing, and reusable rocket returns.

Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.

Complementa, established in 1984 and based in Saint Gallen, Switzerland, offers a range of services to support investors. These include consolidated performance reporting, accounting, investment consulting, and investment control. The company assists clients in planning, designing, and monitoring their investment and financing processes.

Microcaps develops microencapsulation technology that protects and controls the release of active ingredients in pharmaceuticals, probiotics, and cosmetic formulations. Leveraging microfluidics and step emulsification, the company produces monodisperse microcapsules and microparticles at scale, enabling precise size control, dosing, and greater stability. Its platform supports liquid oil core microcapsules with natural alginate shells, improving throughput without quality loss. Based in Zurich, Switzerland, Microcaps targets applications across drug delivery, probiotic encapsulation, and fragrance or cosmetic encapsulation, offering automated encapsulation production capable of high-throughput manufacturing for complex formulations.

Synthara is a Swiss semiconductor company focused on in-memory computing for embedded chips and smart sensor applications. It develops ComputeRAM, a drop-in memory-based compute technology that performs complex calculations directly in memory, reducing CPU workload and improving performance for AI workloads. The technology targets energy-constrained environments and applications including wearables, hearing aids, biomedical monitoring, AR/VR, and industrial IoT sensors, as well as drones, autonomous navigation, space, aerospace, and automotive use cases. Synthara's approach is processor-agnostic and can be integrated with existing microcontrollers to boost energy efficiency and latency without redesigning silicon. The company supports chipmakers and device manufacturers seeking lower costs, shorter time to market, and greater computational throughput. Based in Zurich, Synthara emphasizes enabling seamless adoption of in-memory computing across embedded platforms to extend battery life and unlock new opportunities for intelligent sensing.

Bcomp Ltd., founded in 2003 and headquartered in Fribourg, Switzerland, specializes in manufacturing natural fiber composites. The company's primary products include ampliTex (natural flax fiber), bCores (lightweight wood core), and powerRibs (natural fiber composite reinforcement). Bcomp serves industries such as sports, automotive, acoustics, aerospace, electronics, design, and leisure by providing eco-friendly alternatives to traditional materials.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Food Brewer AG is a Switzerland-based company specializing in the development and marketing of innovative food and food ingredients through the use of plant cell cultures. By employing technologies similar to beer brewing for large-scale cultivation in fermenters, Food Brewer provides sustainable alternatives to traditional agriculture. The company focuses on securing essential resources for the food industry while addressing geographic, climatic, and ethical uncertainties associated with conventional farming practices. Its product offerings include alternatives to cocoa, coffee, nuts, and grains, catering to the evolving needs of clients seeking sustainable food solutions.

Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

Aesyra is a Swiss medical device company based in Lausanne that designs and commercializes intra-oral sensors and compact oral appliances to monitor and manage sleep-related conditions such as bruxism and obstructive sleep apnea. The company develops devices that embed sensors to collect and display metrics, enabling dental professionals to reduce occlusal damages to dental prostheses and helping individuals pursue better sleep. Its offerings include an oral appliance with a customizable liner for optimal fit and sensor-enabled monitoring and management tools for clinicians and patients.

Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

UniSieve develops and manufactures molecular sieving membranes for various applications. Its technology combines different molecular sieves with polymeric membranes to provide reliable separation solutions. UniSieve's products are used in chemical feedstock purification, biogas upgrading, sensing, space-related applications, gas separation, and liquid separation.

Founded in 2018, Nexoya is a Swiss-based company that develops an AI-driven platform for improving marketing performance. It aggregates key performance indicators (KPIs) from various tools and uses predictive analytics to optimize ad budget allocation across channels, enhancing return on ad spend by up to 30%.

Gerald Group is a prominent global commodity trading company that specializes in the physical merchanting, development, and trade of metal products and raw materials. Founded in 1962 and headquartered in Stamford, Connecticut, with additional offices in Morges, Switzerland, and Shanghai, China, the company provides a wide range of nonferrous and precious metals, including copper, aluminum, gold, and silver. Gerald Group serves various sectors, including metal producing, refining, smelting, and banking, by offering services such as commodity trading, logistics, storage, and risk management solutions. The company also engages in project financing, lending, and marketing strategy advisory. Through its strategic partnership with Pengxin International Mining Company, Gerald Group enhances its ability to deliver diverse resources to miners, processors, industrial consumers, and major financial institutions.

Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.

Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.

Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.

Invasight is a clinical biotech company based in Zurich, Switzerland, founded in 2019. The company specializes in advancing cell invasion research with the aim of accelerating the development of targeted therapies for invasive cancers. By focusing on the proteins involved in cancer cell invasion, Invasight aims to create therapies that minimize the side effects typically associated with conventional cancer treatments. This innovative approach seeks to provide cancer patients with effective and safe treatment options tailored to their specific needs.

Founded in 2016, Smeetz is a Swiss-based company offering an AI-powered commerce intelligence platform tailored for the leisure and entertainment industry. Its comprehensive suite of solutions includes ticketing, POS, CRM, data analytics, and dynamic pricing, empowering venues to optimize efficiency, increase revenue, and enhance guest experiences.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.

Founded in 2018, 9T Labs specializes in manufacturing advanced 3D printers that produce carbon composites. Their proprietary technology combines software, additive manufacturing, and industry-standard materials to deliver digital composite production solutions. This enables manufacturers to create lighter structural parts with true 3D fiber orientation at a lower cost.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Odne is a medtech startup based in Renens, Switzerland, specializing in advanced implant technology for the field of endodontics. Founded in 2018, the company focuses on creating light-active medical fillers that facilitate the development of implants within the body through minimally invasive procedures. By utilizing an access channel of less than half a millimeter in diameter, Odne's technology allows physicians to perform surgeries that are not only time-efficient but also aim to deliver optimal patient outcomes. The innovative approach of using light-active fillers enhances the surgical process, positioning Odne as a forward-thinking player in the medical technology landscape.

Nanoleq develops and manufactures electric cables using stretchable electronics, serving sectors such as healthcare, robotics, aerospace, and electronics. Its products include shields and conductors for various applications.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Seervision AG is a Swiss startup founded in 2016 and based in Zurich, specializing in software for camera automation aimed at enhancing video production. Originally conceived at ETH Zurich to improve live lecture recording, the company has evolved into a robust enterprise with a focus on automating workflows in corporate studios, stage events, and educational environments. The Seervision Suite employs advanced video analysis algorithms that utilize motion control technology, integrating computer vision and machine learning to facilitate fully automated productions. This includes features such as autonomous camera tracking, facial recognition, and scene understanding, allowing for seamless integration into corporate settings and significantly simplifying live production processes. With a growing team of over 30 employees, Seervision is committed to making video production effortless and efficient.

Founded in 2017, Scewo designs and manufactures innovative electric wheelchairs for individuals with mobility impairments. Its flagship product is a stair-climbing wheelchair that combines wheels and tracks with an active control system, enabling users to navigate various terrains and obstacles.

Founded in Zurich, Switzerland in 2018, Sleepiz develops a non-contact multidimensional sleep monitoring device. It tracks breathing, heart rate, and body movements with medical-grade accuracy, enabling diagnosis of sleep disorders and long-term patient-centric disease management.

RoomPriceGenie AG, founded in 2017 and based in Steinhausen, Switzerland, specializes in designing and developing revenue management software tailored for hotels, apartments, and vacation rentals. The company's platform offers sophisticated yielding, strategy foresight, and automated updates to optimize room pricing based on demand, occupancy, and availability. By leveraging advanced dynamic pricing algorithms and real-time analytics, RoomPriceGenie ensures optimal pricing strategies. It integrates seamlessly with various property management systems and channel managers, providing both automated pricing adjustments and manual control options. This makes it a versatile tool for small to medium-sized hotels aiming to boost their revenue efficiently. The platform is known for its user-friendly interface and excellent customer support.

ELDICO Scientific AG is a Swiss company founded in 2019 and located at the Switzerland Innovation Park Innovaare, which is affiliated with the Paul Scherrer Institute. The company specializes in the development, manufacturing, and sale of electron diffractometers designed for the analysis of solid compounds, particularly targeting nano-crystalline systems in the sub-micrometer range. ELDICO's innovative instruments enable industrial and scientific researchers to characterize materials that were previously challenging to measure, thereby facilitating advancements in fields such as pharmaceuticals, agrochemicals, and advanced materials research. The company achieved proof of concept for its technology in 2018, with recognition from reputable scientific communities, including being named a Top 5 "Breakthrough of the Year" by a leading journal. This groundbreaking work positions ELDICO as a key player in enhancing the speed and cost-effectiveness of structural analysis, ultimately contributing to faster drug discovery and development processes.

Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Founded in 2018, Nexoya is a Swiss-based company that develops an AI-driven platform for improving marketing performance. It aggregates key performance indicators (KPIs) from various tools and uses predictive analytics to optimize ad budget allocation across channels, enhancing return on ad spend by up to 30%.

Founded in 2017, Apiax specializes in digitalizing complex financial regulations. Its platform transforms regulatory requirements into manageable rules, enabling banks and FinTech companies to embed compliance directly into their workflows.

Microcaps develops microencapsulation technology that protects and controls the release of active ingredients in pharmaceuticals, probiotics, and cosmetic formulations. Leveraging microfluidics and step emulsification, the company produces monodisperse microcapsules and microparticles at scale, enabling precise size control, dosing, and greater stability. Its platform supports liquid oil core microcapsules with natural alginate shells, improving throughput without quality loss. Based in Zurich, Switzerland, Microcaps targets applications across drug delivery, probiotic encapsulation, and fragrance or cosmetic encapsulation, offering automated encapsulation production capable of high-throughput manufacturing for complex formulations.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Artiria Medical develops innovative guidewire systems designed to enhance navigation during neurovascular procedures. Its products feature dynamic tip deflection, superior torque transmission, a high-quality hydrophilic coating, smooth intravascular navigation, adjustability, and a controlled tip deflection mechanism. These devices aim to facilitate complex interventions, reduce procedure-related risks, and improve overall efficiency.

Metaco is a Swiss company that specializes in providing digital asset management solutions for financial institutions. It offers a comprehensive orchestration platform that allows institutions to issue, secure, manage, and trade a diverse range of digital assets, including cryptocurrencies, tokens, and smart contracts. The company’s platform supports the entire lifecycle of asset tokens with a robust smart contract framework, facilitating the management of various asset classes such as equities, bonds, and derivatives. Metaco's technology ensures a secure and agile digital asset vault for self-custody, while also providing connectivity to over 50 exchanges, brokers, and market makers, thus enabling seamless trading and efficient risk management for its clients.

Positrigo develops and manufactures dedicated brain positron emission tomography (PET) scanners. Its mission is to make functional brain imaging accessible for early detection of neurodegenerative diseases like Alzheimer's, Lewy body dementia, vascular dementia, and frontotemporal dementia.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Skribble offers an electronic signature platform that ensures legally binding digital contracts, compliant with Swiss and EU laws. Founded in 2018, it enables users to sign documents electronically with just a few clicks.

PXL Vision is a Swiss identity verification software provider focused on automated, AI-based onboarding and fraud prevention. Its cross-platform Daego solution creates trusted digital identities for customer onboarding by verifying identity documents and performing liveness checks through computer vision and machine learning. Founded in 2017 and headquartered in Zurich, the company operates research and development centers in Novi Sad and Yerevan to advance high-performance ML-based verification. PXL Vision serves industries such as insurance, gambling, fintech, banking and healthcare with a modular, configurable system that supports fully automated identity verification, reduces dropout, improves onboarding conversion, and helps businesses comply with regulatory requirements while protecting customer data. The company emphasizes reliable verifications and safe digital interactions by leveraging proprietary machine learning to confirm document authenticity and user identity.

Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

Klepsydra Technologies GmbH is a software development company based in Zurich, Switzerland, founded in 2017. It specializes in providing a lightweight, platform-agnostic software engineering toolset designed for embedded systems. The company’s software facilitates the development of high-performance applications across various sectors, including aerospace, robotics, autonomous unmanned aerial vehicles, smart mobility, and Internet of Things (IoT) solutions. By offering a cloud computing tool, Klepsydra enables clients to accelerate the development of complex embedded software while optimizing computational performance for demanding tasks such as sensor fusion and image processing. This positions Klepsydra as a versatile enabler of innovation, helping clients achieve ambitious goals through enhanced efficiency and effectiveness in their engineering processes.

Archilyse AG is a Zurich-based software company founded in 2017 that specializes in numeric architectural analysis. The firm offers a Software-as-a-Service solution that enables real estate professionals, including portfolio managers and developers, to analyze and optimize various processes throughout the real estate lifecycle. Archilyse's software converts 2D floor plans into 3D models and utilizes a range of simulations—such as view, geometrical, connectivity, and physical analysis—to derive valuable insights about architectural quality. The application allows users to visualize data through heatmaps and export key performance metrics for further analysis. By addressing the information imbalance in the real estate sector, Archilyse enhances the decision-making capabilities of its clients, promoting a more data-driven approach to property evaluation and portfolio management.

Nagi Bioscience develops automated testing devices that use Caenorhabditis elegans worms to screen molecules for pharmaceutical, chemical and cosmetic applications. Its Organism-on-Chip platform combines whole-organism biology with an automated in vitro workflow for culture, treatment, and multi-parametric analysis, enabling toxicity testing, drug discovery, and anthelmintic screening. The technology links in vivo worm models with a fully automated platform to observe biological responses that emerge at the whole-organism level. The company is headquartered in Lausanne, Switzerland.

Founded in 2018, Resistell develops and markets a diagnostic device for phenotypic antibiotic susceptibility testing. Its unique method detects movement caused by living bacterial cells to determine bacterial resistance to antibiotics.

Qnami AG is a Swiss company that specializes in the development of quantum sensing technologies for non-invasive magnetic imaging at the nanoscale. Founded in 2017 and based in Basel, Qnami's flagship products include the ProteusQ, a magnetic imaging microscope, and the Quantum Diamond, which features diamond probes with a single nitrogen-vacancy center for high-resolution imaging. These technologies allow for advanced applications in various fields, including multiferroic antiferromagnets, magnetic random-access memory (MRAM), and superconductivity. By enabling researchers and industries to measure electric and magnetic fields with exceptional sensitivity, Qnami enhances the capabilities of imaging techniques and supports groundbreaking scientific studies and industrial advancements.

Founded in 2017, Apiax specializes in digitalizing complex financial regulations. Its platform transforms regulatory requirements into manageable rules, enabling banks and FinTech companies to embed compliance directly into their workflows.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

Yonder AG is a Swiss company based in Zurich, founded in 2015, that specializes in documentation-as-a-service (DaaS) solutions. The company's flagship offering, Yonder Mind, is an application designed for efficient information management, enabling organizations to create, maintain, and deliver information effectively to users. Yonder AG focuses on streamlining the documentation process by providing shorter, more relevant documents and manageable revisions, alongside services for document content creation and conversion. Through its innovative solutions, Yonder AG aims to enhance the way businesses handle their information needs.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Wingtra is a Swiss drone manufacturer that designs the WingtraOne, a vertical take-off and landing VTOL fixed-wing drone that combines plane-like efficiency with VTOL versatility to deliver high-precision aerial data for surveying, mapping, and infrastructure projects. The platform supports sectors including construction, mining, agriculture, forestry, environmental monitoring, urban planning, and land management by capturing detailed data over large areas. Founded in 2014 and launching its market-ready product in 2017, Wingtra serves a global customer base through a network of surveying equipment dealers, enabling professionals to digitize and monitor surroundings with reliable flight performance.

Founded in 2016, Eyeware develops software-only head and eye tracking solutions for webcams and 3D cameras. Its patent-pending computer vision algorithms enable accurate, real-time gaze tracking without specialized hardware, benefiting applications such as gaming, research, accessibility, automotive, and healthcare.

xorlab AG is a Swiss cybersecurity firm founded in 2015 and based in Zurich. The company specializes in developing advanced cyber defense solutions, notably its ActiveGuard platform, which protects corporate communication from sophisticated threats such as spear-phishing, ransomware, and zero-day exploits. By leveraging machine intelligence, xorlab enables organizations to detect and neutralize targeted email attacks effectively. With a dedicated team of 14 security professionals and software engineers, xorlab currently safeguards over 50,000 mailboxes, processing more than 1.5 million emails daily for clients in the financial and high-tech sectors in Germany and Switzerland. Through its innovative technologies, xorlab aims to reduce the risk of security breaches and lower operational costs for its customers.

Founded in 2017, TOLREMO therapeutics is a biotechnology company based in Muttenz, Switzerland. It specializes in developing small molecule therapies to target and eradicate cancer cells that cause drug resistance, aiming to prolong the lives of cancer patients.

Hylomorph is a MedTech company that develops biomaterial solutions to improve the interface between implantable medical devices and biological tissue. Its technology includes a cellulose film designed to prevent fibrotic encapsulation and adhesion, helping to reduce postoperative complications such as fibrosis, infection, and device migration, thereby aiming to lower implant failure. The approach combines biotech with surface micro-engineering to optimize tissue implant interaction. First indications target cardiac devices like pacemakers and defibrillators, as well as neurostimulators. The company was founded in 2014 and is headquartered in Zurich, Switzerland.

Founded in 2009, Climeworks develops and operates direct air capture plants that remove carbon dioxide from the atmosphere using low-grade heat. The captured CO2 is then supplied to various industries for applications such as greenhouse fertilization, beverage carbonation, and fuel production.

ProteoMediX is a healthcare company based in Zurich-Schlieren, Switzerland, focused on transforming the diagnosis of prostate cancer. The company has developed innovative biomarker signatures that enhance the accuracy of prostate cancer diagnosis, prognosis, and therapy management. Its lead product, Proclarix®, is a blood-based test panel and risk score that is currently available in Europe. The biomarkers created by ProteoMediX provide improved discrimination between aggressive and indolent forms of cancer, surpassing existing clinical standards. This advancement enables physicians to make more informed treatment decisions for their patients, ultimately aiming to improve outcomes in prostate cancer care.

Aspivix develops innovative medical devices aimed at enhancing safety and comfort in gynecological procedures. Its flagship product, CAREVIX, employs suction technology to gently stabilize the cervix during procedures, reducing pain and minimizing risks such as bleeding and infections.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

Cutiss AG is a biotechnology company specializing in the bio-engineering of customized human skin grafts, known as denovoSkin. The innovative process begins with a small biopsy of healthy skin from the patient, which is then used to generate large quantities of grafts tailored to individual needs. This approach aims to minimize scarring following transplantation, making it particularly beneficial for patients with severe burns. denovoSkin has garnered recognition and received Orphan drug designation from Swissmedic, the European Medicines Agency, and the FDA for its potential in treating burn injuries.

TestingTime AG is a Swiss company founded in 2014 and based in Zurich, specializing in online test user recruitment for usability studies, focus groups, interviews, and surveys. The company serves the UX and market research sectors by providing access to a diverse pool of over 350,000 test users, facilitating the selection of participants tailored to specific research needs. TestingTime employs online campaigns and referral strategies to acquire test users, while utilizing a smart rating system and predictive machine learning algorithms to ensure high-quality participants with a low no-show rate. Its services are offered in multiple languages, including German, French, Italian, Romansh, and English. TestingTime's platform enables large corporations, such as UBS, Zalando, Microsoft, and Accenture, to conduct qualitative and quantitative user research efficiently, enhancing their ability to gather valuable insights.

Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Abionic develops innovative nanotechnology-based diagnostic solutions. Its flagship product, abioSCOPE, enables rapid allergy profiling from a single drop of blood, improving medical diagnosis at clinical labs and point-of-care settings.

Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Pregnolia AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in the development of a diagnostic device that predicts the risk of premature birth during pregnancy. The company's core product is a medical probe that measures the strength of the uterine cervix, empowering healthcare professionals to intervene preventively and enhance neonatal health outcomes. Pregnolia's mission is to ensure every woman experiences a happy, healthy, and informed pregnancy, working closely with pregnant women and gynecologists to achieve this goal. The company is committed to completing clinical trials, navigating regulatory pathways, and commercializing its device to successfully support gynecologists in improving preterm birth risk assessment and management.

Picstars AG, established in 2014 and headquartered in Zürich, Switzerland, operates an online platform that connects brands with suitable influencers, particularly in the sports and lifestyle sectors. The company's core service involves helping brands identify and collaborate with appropriate brand ambassadors who can promote their products or services through their own social media channels. Picstars' platform enables brands to create and manage campaigns, track performance, and measure the success of their influencer marketing efforts. Recognized as one of the top 10 tech startups in Switzerland, Picstars aims to digitize the sponsorship of brand ambassadors, streamlining the process for both brands and influencers.

Founded in 2013, Embotech develops decision-making software solutions for autonomous systems. Its flagship product, FORCES Pro, enables complex control system design across industries such as automotive, energy, and robotics. Applications include wind turbine control, drone motion planning, advanced driver assistance systems (ADAS), spacecraft landing, and reusable rocket returns.

QualySense develops and markets sorting technology for grains, seeds and beans. Its systems inspect and monitor processing and support research by sorting individual kernels based on biochemical and physical properties. The flagship sorter combines machine vision and hyperspectral near-infrared spectroscopy to measure components such as oil, protein and moisture, as well as attributes like size, shape and color, at high speed. This enables segregation of batches into quality classes, allowing customers to premiumize products and improve production value. The company serves seed breeders, food companies and inspection agencies and aims to enable continuous, high-throughput processing. Founded in 2009 and based in Glattbrugg, Switzerland.

Founded in 2017, Apiax specializes in digitalizing complex financial regulations. Its platform transforms regulatory requirements into manageable rules, enabling banks and FinTech companies to embed compliance directly into their workflows.

Peripal AG, established in 2015 and headquartered in Zurich, Switzerland, specializes in developing and distributing innovative medical devices designed to assist patients undergoing Peritoneal Dialysis at home. Their flagship product, PeriSafe, is a patient-assist device that simplifies the process of connecting dialysis tubings manually, reducing the risk of infection and requiring less dexterity from users. Additionally, they offer PERiPLEX, a diagnostic tool for detecting infections in peritoneal dialysis patients. Peripal's primary focus is on developing products like the Peripal System to support chronic home care patients, aiming to enhance their quality of life while reducing healthcare costs.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, Versantis aims to address significant unmet medical needs for patients globally. Its lead candidate, VS-01, is currently in preclinical development and has the potential to be the first treatment for acute liver disease while simultaneously supporting multiple failing organs. VS-01 has received Orphan Drug Designation for its application in acute liver failure. The company also has additional treatments in its pipeline, including VS-02 and VS-03, which target chronic liver diseases and drug intoxications, respectively. These developments represent substantial market opportunities and underscore Versantis' commitment to improving patient outcomes for millions affected by liver conditions and related disorders.

ProteoMediX is a healthcare company based in Zurich-Schlieren, Switzerland, focused on transforming the diagnosis of prostate cancer. The company has developed innovative biomarker signatures that enhance the accuracy of prostate cancer diagnosis, prognosis, and therapy management. Its lead product, Proclarix®, is a blood-based test panel and risk score that is currently available in Europe. The biomarkers created by ProteoMediX provide improved discrimination between aggressive and indolent forms of cancer, surpassing existing clinical standards. This advancement enables physicians to make more informed treatment decisions for their patients, ultimately aiming to improve outcomes in prostate cancer care.

Piavita AG, founded in 2016 and headquartered in Zurich, Switzerland, specializes in developing advanced technology for the veterinary industry. The company has created a compact, matchbox-sized wearable device that accurately measures vital medical data from pets, including horses, without the need for clipping fur or extensive preparation. This innovative system is complemented by a web-based application that enables real-time monitoring and historical tracking of vital signs, improving the diagnostic capabilities available to veterinarians. By providing reliable insights into pet health and facilitating better communication between pet owners and veterinary professionals, Piavita aims to lead the digital transformation of veterinary care, addressing the gaps in current veterinary practices and enhancing the overall wellbeing of animals.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Polyneuron Pharmaceuticals AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative therapeutics for the treatment of autoimmune disorders. Founded in 2014, the company specializes in creating drugs to target specific autoimmune conditions, including PN-1007 for anti-MAG neuropathy, PN-1018 for multifocal motor neuropathy, and PN-032 and PN-056 for ABO-incompatible transplantation. Polyneuron's therapeutic approach employs biodegradable glycopolymers that selectively eliminate pathological autoantibodies, preserving the overall integrity of the immune system. This technology, referred to as Antibody-Catch, aims to provide safe and effective treatment options for patients suffering from autoimmune diseases affecting the peripheral nervous system, particularly those involving autoantibodies against carbohydrate epitopes.

Fanpictor is a Swiss technology company specializing in innovative digital and on-site fan engagement solutions for brands and rights holders. The company creates immersive, fan-driven experiences that foster lasting connections between fans, teams, rights holders, and brands. Fanpictor's digital toolkit enables clients' marketing and creative teams to develop unique campaigns tailored to specific events or series of games, collecting commercially validated data to assess the success of these initiatives and engagement levels across different demographics. All solutions are fully white-labeled and can be accessed through dedicated event apps or integrated into existing brand, league, or team apps. Additionally, Fanpictor helps create venue-specific choreographies to enhance fan experiences.

Memo Therapeutics AG is a Swiss biotechnology company based in Basel, specializing in antibody discovery and immune repertoire analysis. The company has developed the MemoMAB platform, which generates a recombinant in vitro copy of an individual’s B cell or antibody repertoire, creating a comprehensive library of unique antibodies. This innovative technology allows for the identification of a vast array of relevant and rare antibodies, significantly enhancing the potential for immune repertoire analysis and antibody discovery. Memo Therapeutics aims to leverage its platform in proprietary antibody lead discovery programs and through collaborations, with a focus on improving treatment options for patients suffering from viral infections and cancer.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Medyria is a Swiss medtech company developing sensor-based catheter navigation and sensing systems for vascular, valve, and heart procedures. Its products include a sensor-based catheter positioning system for X-ray- and dye-free minimally invasive cardiovascular procedures, Flowcath for measuring blood flow, Trackcath for processing flow data and tracking catheters, and an OEM flow sensor for measuring blood or physiological fluid flow. The company uses proprietary Blood Flow Velocity Sensor technology to enable safer and more effective endovascular procedures by reducing procedural manipulations, duration, complications, and overall costs. Medyria is based in Winterthur, Switzerland.

Bluetector AG is a Swiss company specializing in the manufacture of wastewater treatment machinery, particularly focusing on the treatment of manure and biogas digestate. Established in 2012 and based in Root, Switzerland, Bluetector produces innovative wastewater treatment containers and systems. The company's technology provides a cost-effective solution for farms struggling with excess manure by converting it into clean water, thus eliminating the need for costly transport over long distances. By utilizing a containerized filtering system based on biological purification methods, Bluetector offers a sustainable approach to managing liquid waste, allowing environmental companies to clean and reuse wastewater in an environmentally friendly manner. Additionally, the company is involved in constructing and renovating municipal wastewater treatment plants, further contributing to effective wastewater management solutions.

Ampard AG is a Swiss company based in Zurich that specializes in the development and marketing of energy management systems across Europe. Since its inception in 2011, Ampard has focused on optimizing the control of distributed renewable power plants and implementing demand response solutions. The company's flagship product, the AMPARD energy management system, is designed for residential and small commercial customers, enabling the efficient management of renewable assets and storage systems. By facilitating the creation of virtual power plants and integrating various devices for demand response, Ampard is recognized as a leader in energy innovation, particularly in the realm of decentralized power management.

iMusician Digital AG is a Swiss-based online platform founded in 2007, dedicated to empowering musicians in managing, selling, and monetizing their music. Located in Zurich, the company offers a comprehensive suite of tools that enables artists to distribute their music across major streaming services and sales platforms. iMusician focuses on simplifying the process for musicians by providing real-time sales tracking and copyright management, allowing them to concentrate on their creative work. With a small, passionate international team, iMusician Digital strives to support artists in navigating the complexities of the music industry and maximizing their revenue potential.

Founded in 2009, Climeworks develops and operates direct air capture plants that remove carbon dioxide from the atmosphere using low-grade heat. The captured CO2 is then supplied to various industries for applications such as greenhouse fertilization, beverage carbonation, and fuel production.

ProteoMediX is a healthcare company based in Zurich-Schlieren, Switzerland, focused on transforming the diagnosis of prostate cancer. The company has developed innovative biomarker signatures that enhance the accuracy of prostate cancer diagnosis, prognosis, and therapy management. Its lead product, Proclarix®, is a blood-based test panel and risk score that is currently available in Europe. The biomarkers created by ProteoMediX provide improved discrimination between aggressive and indolent forms of cancer, surpassing existing clinical standards. This advancement enables physicians to make more informed treatment decisions for their patients, ultimately aiming to improve outcomes in prostate cancer care.

Zkipster GmbH is an event management platform based in Zurich, Switzerland, founded in 2009. The company specializes in providing software solutions for live, virtual, and hybrid events, enabling seamless event planning and execution. Zkipster's offerings include powerful tools for guest management, custom communications via email, SMS, and WhatsApp, as well as online and offline event check-in. The platform also features real-time session and capacity management, dynamic seating charts, and QR code integration, facilitating efficient guest interactions while minimizing contact. With its innovative zFace technology, a picture matching search engine integrated into the guest list solution, Zkipster is trusted by global brands and renowned organizations to enhance event experiences and foster relationships with guests.

Uepaa AG, based in Zurich, Switzerland, specializes in peer-to-peer communication technology for mobile devices. Founded in 2012 by Mathias Haussmann and Dr. Franck Legendre, the company has developed an innovative software solution that allows mobile applications to establish direct connections, even in the absence of cellular or internet coverage. Its flagship product, the Uepaa! Safety app, launched in 2013, is designed to provide safety protection for lone workers and field employees by enabling features such as accident detection and emergency alerts. This app has become an industry standard for mobile-based safety solutions, serving thousands of users and meeting the growing demand for enhanced worker safety in various environments. Uepaa AG's technology platform, known as Proximity SDK p2pkit, allows devices to communicate and share information when in close proximity, further enhancing its applications in safety and emergency response.

arviem provides global cargo monitoring and supply chain visibility services, offering fully managed in-transit tracking and security monitoring across land, sea, and air. The company combines sensing, analytics, and operations support with advisory services such as business consulting and system integration to help clients optimize supply chains. Its platform delivers real-time data on shipment location and condition, enabling data-driven decisions related to logistics, risk management, and working capital. Serving industries including consumer products, consumer electronics, pharma and biochemical, chemical, logistics, and insurance, arviem operates across Europe, Asia, and the Americas. It offers 24/7 global monitoring through a managed service model and provides independent data to support trust and transparency. Strategic partnerships in technology and logistics enhance capabilities in tracking, security, and compliance. Headquartered in Rotkreuz, Switzerland, arviem supports importers, exporters, and logistics providers seeking end-to-end visibility of cargo movements.

MySwissChocolate AG, established in 2010 and headquartered in Root, Switzerland, specializes in the production and marketing of chocolates. The company operates an online platform that allows users to design and purchase custom-made chocolates. MySwissChocolate's products are available both domestically in Switzerland and internationally, catering to a global market through its e-commerce channels.

Creoptix AG is a Swiss company specializing in the development of optical instruments and consumables for label-free analysis of molecular interactions, primarily serving the drug discovery industry. Founded in 2009 and headquartered in Wädenswil, Switzerland, with an additional office near Boston, Creoptix focuses on next-generation bioanalytical instruments that leverage proprietary sensor and microfluidics technology. Their flagship product, the Creoptix WAVEsystem, utilizes Grating-Coupled Interferometry (GCI) technology to offer high sensitivity and resolution for real-time analysis of biological interactions, accommodating various samples, including small molecules, peptides, and biologics in complex biofluids like serum and plasma. The company also provides instrument sets for fragment-based screening and binding analysis, versatile sensors for carboxyl-coupling of various molecules, and integrated software for assay setup and data evaluation, catering to both industry and academic research needs.

SWISSto12 SA is a Swiss company that specializes in the manufacture and supply of radio frequency (RF) and microwave components and systems. Founded in 2011 as a spin-off from the Swiss Federal Institute of Technology in Lausanne, the company is based in Renens, Switzerland, with additional offices in Santa Clara, California, and Rehovot, Israel. SWISSto12 offers a range of products including various types of horn antennas, airborne antenna arrays, waveguide antennas, and custom-designed antennas and filters. The company is known for its innovative use of metal-coated 3D printing technology, which enhances design flexibility while reducing costs, lead times, and weight. Its offerings extend to polymer and metal waveguide products, as well as integration and testing services. SWISSto12 serves clients in satellite communications, airborne satellites, and research centers, and is also developing software solutions for material properties extraction.